NRDS enters its Q1 2026 earnings today having shed roughly one-fifth of its short interest over the past month — a notable de-risking of the bear trade before the print.
Short interest has fallen 19% over 30 days to 10.9% of the free float, down from above 16% in early April when the broader market was at its most turbulent. The retreat is the clearest feature of the setup: bears who loaded up during the April selloff have since covered, and the borrow market confirms the release of pressure — cost to borrow has halved over the same period to just 0.48%, the lowest it has been since before the tariff shock. Availability remains ample. The short score of 60.9 is elevated in absolute terms but has been remarkably stable for weeks, suggesting no fresh wave of shorting is building into the report.
Options positioning adds a complementary layer of caution from the bull side. The put/call ratio has tumbled to 0.79, well below its 20-day average of 0.95 — about 1.1 standard deviations below the mean. That reversal is striking given the PCR was above 1.5 through most of early April. Traders have rotated sharply from downside protection toward calls in the past three weeks, a move that tracked NRDS's 8% recovery to $11.20 over the past month.
The analyst community is split, and the disagreement is structural rather than tactical. Morgan Stanley downgraded to Underweight in March, cutting its target to $9 — the only recent rating change from a bellwether firm, and it landed squarely below the current price. Oppenheimer and Truist both maintained positive ratings after February's earnings beat but trimmed targets into the $15–$18 range. That range implies 35–60% upside from current levels, a gap that reflects genuine disagreement about whether the company's growth in loans and insurance can offset persistent headwinds in its SMB and organic-search-dependent segments. The bull case rests on cost discipline and a mortgage broker acquisition sustaining momentum. The bear case is more pointed: declining organic search traffic is structurally eroding the SMB revenue line, and forward guidance has already been marked down twice. At an EV/EBITDA of roughly 4.5x and a P/E below 7x, the valuation is undemanding — the stock trades at a fraction of sector peers — but cheap multiples in consumer finance often reflect a revenue visibility problem rather than genuine value.
One data point worth noting: the last confirmed earnings event, in late February, produced a one-day jump of nearly 16% and a five-day gain of almost 17%. That reaction followed a Q4 beat. A repeat of that magnitude would require another clean beat with credible full-year guidance — and this print arrives with the SMB headwind still live and Morgan Stanley freshly on the sidelines.
The Q1 report is therefore less a debate about NerdWallet's long-term model and more a test of whether the company can show the loans and insurance momentum is durable enough to hold the bulls' case together without the tailwind of broader market anxiety driving PCR higher.
See the live data behind this article on ORTEX.
Open NRDS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
